Endo International plc - FORM 10-Q - EX-10.307 - RRA 2025 NOTES - November 9, 2015

Attached files

file filename
EX-10.31.1 - NOVARTIS FIRST AMENDMENT TO LICENSE AGREEMENT - Endo International plcex-10311novartisconsumerhe.htm
EX-10.308 - SUPPLEMENTAL INDENTURE 5.75% 2022 NOTES - Endo International plcex-10308supp_indenturex5x7.htm
EX-10.305 - RRA 2023 NOTES - Endo International plcex-10305rra_counterpartx5x.htm
EX-10.301 - RRA 2020 NOTES - Endo International plcex-10301rracounterpart_7x0.htm
EX-10.31 - NOVARTIS LICENSE AGREEMENT - Endo International plcex-1031novartisconsumerhea.htm
EX-10.309 - SUPPLEMENTAL INDENTURE 6.00% 2023 NOTES - Endo International plcex-10309supp_indenturex6x0.htm
EX-10.310 - CAMPANELLI EMPLOYMENT AGREEMENT - Endo International plcex-10310employmentagreemen.htm
EX-10.304 - SUPPLEMENTAL INDENTURE 2023 NOTES - Endo International plcex-10304supp_indenturex5x3.htm
EX-10.302 - SUPPLEMENTAL INDENTURE 2022 NOTES - Endo International plcex-10302supp_indenturex7x2.htm
EX-10.306 - SUPPLEMENTAL INDENTURE 2025 NOTES - Endo International plcex-10306suppindenture_6x00.htm
EX-10.303 - RRA 2022 NOTES - Endo International plcex-10303rracounterpart7_25.htm
EX-31.2 - CFO SECTION 302 CERTIFICATION - Endo International plcex3129302015cfo302cert.htm
EX-32.1 - CEO SECTION 906 CERTIFICATION - Endo International plcex3219302015ceo906cert.htm
EX-31.1 - CEO SECTION 302 CERTIFICATION - Endo International plcex3119302015ceo302cert.htm
EX-32.2 - CFO SECTION 906 CERTIFICATION - Endo International plcex3229302015cfo906cert.htm
10-Q - 10-Q - Endo International plcendp-9302015x10q.htm
EX-10.300 - SUPPLEMENTAL INDENTURE 2020 NOTES - Endo International plcex-10300supp_indenturex7x0.htm
EX-10.31.2 - NOVARTIS SECOND AMENDMENT TO LICENSE AGREEMENT - Endo International plcex-10312novartisconsumerhe.htm
Exhibit 10.307


Counterpart to Registration Rights Agreement
September 30, 2015
Each of the undersigned hereby absolutely, unconditionally and irrevocably agrees as a Guarantor, as defined in the Registration Rights Agreement, dated January 27, 2015 by and among Endo Finance LLC, a Delaware limited liability company, Endo Finco Inc., a Delaware corporation, and Endo Designated Activity Company, an Irish private limited company, the Guarantors party thereto, RBC Capital Markets, LLC and Citigroup Global Markets Inc., relating to the 6.00% Senior Notes due 2025, to be bound by the terms and provisions of such Registration Rights Agreement.
[Signature Pages Follow]



IN WITNESS WHEREOF, each of the undersigned has executed this counterpart as of the date first written above.

PAR PHARMACEUTICAL COMPANIES, INC.
as a Guaranteeing Subsidiary
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 
 
 
 
 
 
 
 
 
 
 
 
 
PAR PHARMACEUTICAL, INC.
as a Guaranteeing Subsidiary
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 
 
 
 
 
 
 
 
 
 
 
 
 
ANCHEN INCORPORATED
as a Guaranteeing Subsidiary
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 
 
 
 
 
 
 
 
 
 
 
 
 
PAR, INC.
as a Guaranteeing Subsidiary
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 




[Signature to Registration Rights Agreement Counterpart – 6.00% Senior Notes due 2025]

JHP GROUP HOLDINGS, INC.
as a Guaranteeing Subsidiary
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 
 
 
 
 
 
 
 
 
 
 
 
 
JHP ACQUISITION, LLC
as a Guaranteeing Subsidiary
by JHP GROUP HOLDINGS, INC., as Manager
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 
 
 
 
 
 
 
 
 
 
 
 
 
PAR STERILE PRODUCTS, LLC
as a Guaranteeing Subsidiary
by JHP ACQUISITION, LLC, as Manager
by JHP GROUP HOLDINGS, INC., its manager
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 







[Signature to Registration Rights Agreement Counterpart – 6.00% Senior Notes due 2025]

ANCHEN PHARMACEUTICALS, INC.
as a Guaranteeing Subsidiary
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 






[Signature to Registration Rights Agreement Counterpart – 6.00% Senior Notes due 2025]

KALI LABORATORIES, INC.
as a Guaranteeing Subsidiary
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 
   


[Signature to Registration Rights Agreement Counterpart – 6.00% Senior Notes due 2025]

INNOTEQ, INC.
as a Guaranteeing Subsidiary
 
 
 
 
 
 
 
 
By:
/s/
Deanna Voss
 
Name:
Deanna Voss
 
Title:
Assistant Secretary
 






[Signature to Registration Rights Agreement Counterpart – 6.00% Senior Notes due 2025]

PAR LABORATORIES EUROPE, LTD
as a Guaranteeing Subsidiary
 
 
 
 
 
 
 
 
By:
/s/
Orla Dunlea
 
Name:
Orla Dunlea
 
Title:
Director
 


[Signature to Registration Rights Agreement Counterpart – 6.00% Senior Notes due 2025]

ENDO FINANCE IV LIMITED
as a Guaranteeing Subsidiary
 
 
 
 
 
 
 
 
By:
/s/
Orla Dunlea
 
Name:
Orla Dunlea
 
Title:
Director
 


[Signature to Registration Rights Agreement Counterpart – 6.00% Senior Notes due 2025]

Stock widget

Investing forum

Endo International plc Reports

Also read